RE: CNDO $2.06 imploded today on pitiful results on clinical trial....I am attaching part of an article from 24/7 Wall St. here that got my attention "Now Coronado has to put all of its efforts into its CNDO-109 study. This is the other pipeline candidate, a biologic that activates natural killer cells for the treatment of acute myeloid leukemia and solid tumors. Other study indications for the TSO drug are for ulcerative colitis, multiple sclerosis, autism spectrum disorders and psoriasis.
Shortly before Noon on Monday, Coronado's shares were down a whopping 67% at $1.89, and they had traded as low as $1.73 earlier in the morning. The 52-week high is $12.70, and the new market cap is only about $60 million. The company's cash balance was almost $68 million, and its net tangible assets were $48.5 million as of June 30, 2013."
fwiw....tuna
